4
Views
15
CrossRef citations to date
0
Altmetric
Original Article

Proteinuria in Patients with Uroepithelial Tumours with Special Regard to Tumour Size, Clinical Staging and Grade of Malignancy

&
Pages 45-49 | Accepted 18 Jan 1974, Published online: 09 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Patrick C. J. Ward. (1981) Renal dysfunction. Postgraduate Medicine 69:6, pages 91-99.
Read now
L. Hemmingsen & P. Skaarup. (1977) Urinary Excretion of Ten Plasma Proteins in Patients with Renal Carcinoma. Scandinavian Journal of Urology and Nephrology 11:1, pages 41-46.
Read now
Bengt Johansson. (1975) Urinary Protein Patterns in Patients with Uroepithelial Tumours: Effect of Surgery and Radiotherapy. Scandinavian Journal of Urology and Nephrology 9:3, pages 221-225.
Read now

Articles from other publishers (12)

Jang Hee Han, Seung-hwan Jeong, Hyeong Dong Yuk, Chang Wook Jeong, Cheol Kwak & Ja Hyeon Ku. (2022) Acidic urine is associated with poor prognosis in patients with bladder cancer undergoing radical cystectomy. Frontiers in Oncology 12.
Crossref
Masanori Sakakima, Yoshihide Fujigaki, Hideo Yasuda, Akashi Togawa, Tomoyuki Fujikura, Atsushi Otsuka, Seiichiro Ozono & Akira Hishida. (2011) A Case with Significant Proteinuria Caused by Secreted Protein from Urothelial Carcinoma. Case Reports in Nephrology 2011, pages 1-4.
Crossref
Christine P. Diggle, Sheena Cruickshank, Jonathon D. Olsburgh, Stephanie Pellegrin, Barbara Smith, Rosamonde E. Banks, Peter J. Selby, Margaret A. Knowles, Jennifer Southgate & Patricia Harnden. (2003) Identification of Genes Up-Regulated in Urothelial Tumors. The American Journal of Pathology 163:2, pages 493-504.
Crossref
A S Protheroe, R E Banks, M Mzimba, W H Porter, J Southgate, P N Singh, M Bosomworth, P Harnden, P H Smith, P Whelan & P J Selby. (1999) Urinary concentrations of the soluble adhesion molecule E-cadherin and total protein in patients with bladder cancer. British Journal of Cancer 80:1-2, pages 273-278.
Crossref
H. Huland, R. Arndt, E. Huland, Th. Loening & M. Steffens. (1987) Monoclonal Antibody 486 P 3/12: A Valuable Bladder Carcinoma Marker for Immunocytology. Journal of Urology 137:4, pages 654-659.
Crossref
R. EWING, G. M. TATE & J. W. HETHERINGTON. (2008) Urinary Fibrin/Fibrinogen Degradation Products in Transitional Cell Carcinoma of the Bladder. British Journal of Urology 59:1, pages 53-58.
Crossref
E.P. Lillehoj & M.D. Poulik. (1986) Normal and abnormal aspects of proteinuria. Experimental pathology 29:1, pages 1-28.
Crossref
Ciril J. Godec. 1985. Proteinuria. Proteinuria 127 132 .
R. Joseph Babaian, Deborah A. Watson & Joe M. Jones. (1984) Immune Complexes in Urine and Serum of Patients with Bladder Cancer. Journal of Urology 131:3, pages 463-466.
Crossref
L. HEMMINGSEN, F. RASMUSSEN, P. SKAARUP & H. WOLF. (2008) Urinary Protein Profiles in Patients with Urothelial Bladder Tumours. British Journal of Urology 53:4, pages 324-329.
Crossref
Patricia O’brien, James J. Gozzo & Anthony P. Monaco. (1980) Urinary Proteins as Biological Markers: Bladder Cancer Diagnosis Versus Urinary Tract Infection. Journal of Urology 124:6, pages 802-803.
Crossref
James J. Gozzo, Rita Gottschalk, Patricia O’Brien, William Cronin & Anthony P. Monaco. (1977) Use of Heterogenous and Monospecific Antisera for the Diagnosis of Bladder Cancer. Journal of Urology 118:5, pages 748-751.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.